Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aylin Sertkaya

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Applied Health Economics and Health Policy|September 8, 2016
Promoting Antibacterial Drug Development: Select Policies and ChallengesAylin Sertkaya, Amber Jessup, Hui-Hsing Wong
JAMA Network Open|September 14, 2022
Estimated Cost of Developing a Therapeutic Complex Medical Device in the USAylin Sertkaya, Rebecca DeVries, Amber Jessup, et al.
Clinical Trials (London, England)|February 25, 2016
Key cost drivers of pharmaceutical clinical trials in the United StatesAylin Sertkaya, Hui-Hsing Wong, Amber Jessup, et al.
JAMA Network Open|June 28, 2024
Costs of Drug Development and Research and Development Intensity in the US, 2000-2018Aylin Sertkaya, Trinidad Beleche, Amber Jessup, et al.
American Journal of Infection Control|December 24, 2018
Societal willingness to pay to avoid mortality and morbidity from Clostridioides difficile and carbapenem-resistant Enterobacteriaceae infections in the United StatesAylin Sertkaya, Hui-Hsing Wong, Daniel H Ertis, et al.
Pharmacoeconomics - Open|September 26, 2025
Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug ManufacturerAylin Sertkaya, Zeid El-Kilani, Sean Klein, et al.
Journal of Food Protection|January 8, 2025
Costs of Overly Broad RecallsNyssa Ackerley, Ayesha Berlind, Michael Black, et al.
International Journal of Antimicrobial Agents|December 10, 2023
Assessing the state of antibacterial drug discovery through patent analysisAylin Sertkaya, J Daniel McGeeney, Casey Sullivan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 23, 2025
Measuring the First Mover Advantage in US Biosimilar MarketsJ Daniel McGeeney, Aylin Sertkaya, Samantha A McCormick, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2021
The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic ReviewChristopher J Cadham, Marie Knoll, Luz María Sánchez-Romero, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Applied Health Economics and Health Policy|September 8, 2016
Promoting Antibacterial Drug Development: Select Policies and ChallengesAylin Sertkaya, Amber Jessup, Hui-Hsing Wong
JAMA Network Open|September 14, 2022
Estimated Cost of Developing a Therapeutic Complex Medical Device in the USAylin Sertkaya, Rebecca DeVries, Amber Jessup, et al.
Clinical Trials (London, England)|February 25, 2016
Key cost drivers of pharmaceutical clinical trials in the United StatesAylin Sertkaya, Hui-Hsing Wong, Amber Jessup, et al.
JAMA Network Open|June 28, 2024
Costs of Drug Development and Research and Development Intensity in the US, 2000-2018Aylin Sertkaya, Trinidad Beleche, Amber Jessup, et al.
American Journal of Infection Control|December 24, 2018
Societal willingness to pay to avoid mortality and morbidity from Clostridioides difficile and carbapenem-resistant Enterobacteriaceae infections in the United StatesAylin Sertkaya, Hui-Hsing Wong, Daniel H Ertis, et al.
Pharmacoeconomics - Open|September 26, 2025
Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug ManufacturerAylin Sertkaya, Zeid El-Kilani, Sean Klein, et al.
Journal of Food Protection|January 8, 2025
Costs of Overly Broad RecallsNyssa Ackerley, Ayesha Berlind, Michael Black, et al.
International Journal of Antimicrobial Agents|December 10, 2023
Assessing the state of antibacterial drug discovery through patent analysisAylin Sertkaya, J Daniel McGeeney, Casey Sullivan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 23, 2025
Measuring the First Mover Advantage in US Biosimilar MarketsJ Daniel McGeeney, Aylin Sertkaya, Samantha A McCormick, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2021
The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic ReviewChristopher J Cadham, Marie Knoll, Luz María Sánchez-Romero, et al.
Pageof 2